Cargando…
Targeted therapy monitoring of BRAF-V600-mutant Erdheim-Chester disease by fast quantitative whole-body bone CZT-tomoscintigraphies
Erdheim-Chester disease (ECD) is a rare histiocytosis due to proto-oncogene mutations, primarily affecting the long bones and possibly being treated by novel targeted therapies. (18)F-FDG PET is a reference technique for ECD assessment. However, we present a case where easier and more objective moni...
Autores principales: | Melki, Saifeddine, Moulinet, Thomas, Verger, Antoine, Marie, Pierre-Yves, Imbert, Laetitia, Bahloul, Achraf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837338/ https://www.ncbi.nlm.nih.gov/pubmed/36635469 http://dx.doi.org/10.1186/s41824-022-00160-3 |
Ejemplares similares
-
Tracheobronchitis signs observed on ventilation lung scintigraphy during the course of COVID-19 infection
por: Verger, Antoine, et al.
Publicado: (2020) -
Vemurafenib for BRAF V600‐mutant Erdheim–Chester disease presenting with bilateral orbital involvement
por: Wang, Xiaomeng, et al.
Publicado: (2023) -
Erdheim-Chester Disease With BRAF V600E Mutation and Central Diabetes Insipidus Successfully Treated With Glucocorticoid
por: Imaizumi, Toshinori, et al.
Publicado: (2023) -
BRAF V600E mutations in urine and plasma cell-free DNA from patients with Erdheim-Chester disease
por: Janku, Filip, et al.
Publicado: (2014) -
Erdheim–Chester disease presenting as acute ischaemic cardiomyopathy and aortitis in a BRAF V600E-negative patient
por: Nicolas, Anthony J, et al.
Publicado: (2021)